KYNTRA BIO, INC.
Pharmaceutical Preparations · SAN FRANCISCO · CA
Moderate confidence (50%)
Updated Oct 11, 2026, 12:08 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: KYNTRA BIO, INC. received a delisting notice from its exchange (Sep 30, 2026)
Timeline
Every material event, newest first. History is never overwritten.
KYNTRA BIO, INC. received a delisting notice from its exchange
Sep 30, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 30, 2026, Kyntra Bio, Inc. (the Company or Kyntra Bio ) received a determination letter ( Determination ) from the Listing Qualifications Staff (the Staff ) of the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it had not yet demonstrated compliance with Nasdaq Listing Rule 5450(b) as of the September 29, 2026 deadline and that, as a result, the Staff had determined to delist the Company s common stock from the Nasdaq Global Select Market. The Company has t…”
KYNTRA BIO, INC. received a delisting notice from its exchange
Apr 2, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 2, 2026, Kyntra Bio, Inc. ( Kyntra Bio or the Company ) received a letter from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market notifying us that the Company no longer complies with the Nasdaq Global Select Market continued listing requirement of $50 million in total assets and total revenue for the most recently completed fiscal year (or two of the last three most recently completed fiscal years) per Listing Rule 5450(b)(3)(A). This is due to the revenue of…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker KYNB on Nasdaq.
- SEC CIK
- 0000921299
- Website
- —
- —
- Headquarters
- SAN FRANCISCO, CA
- Also known as
- FIBROGEN INC
- Legal entities
- KYNTRA BIO, INC.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 30, 2026, Kyntra Bio, Inc. (the Company or Kyntra Bio ) received a determination letter ( Determination ) from the Listing Qualifications Staff (the Staff ) of the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it had not yet demonstrated compliance with Nasdaq Listing Rule 5450(b) as of the September 29, 2026 deadline and that, as a result, the Staff had determined to delist the Company s common stock from the Nasdaq Global Select Market. The Company has t…
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
KYNTRA BIO, INC. — Pharmaceutical Preparations (SIC 2834) — SAN FRANCISCO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 2, 2026, Kyntra Bio, Inc. ( Kyntra Bio or the Company ) received a letter from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market notifying us that the Company no longer complies with the Nasdaq Global Select Market continued listing requirement of $50 million in total assets and total revenue for the most recently completed fiscal year (or two of the last three most recently completed fiscal years) per Listing Rule 5450(b)(3)(A). This is due to the revenue of…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.